PubMed Health⌕ Search

Biomedical subjects

H Borel

Publications and source records attributed to H Borel.

At least 37 records · Page 2Linked to original sources
PubMed2003

Elliptic flow of identified hadrons in Au+Au collisions at sqrt sNN =200 GeV.

The anisotropy parameter (v(2)), the second harmonic of the azimuthal particle distribution, has been measured with the PHENIX detector in Au+Au collisions at sqrt[s(NN)]=200 GeV for identified and inclusive charged particle production at central rapidities (|eta|<0.35) with respect to the reaction plane defined at high rapidities (|eta|=3-4 ). We observe that the v(2) of mesons falls below that of (anti)baryons for p(T)>2 GeV/c, in marked contrast to the predictions of a hydrodynamical model. A quark-coalescence model is also investigated.

Journal Article↗
PubMed2003

Scaling properties of proton and antiproton production in sqrt[s(NN)]=200 GeV Au+Au collisions.

We report on the yield of protons and antiprotons, as a function of centrality and transverse momentum, in Au+Au collisions at sqrt[s(NN)]=200 GeV measured at midrapidity by the PHENIX experiment at the BNL Relativistic Heavy Ion Collider. In central collisions at intermediate transverse momenta (1.5<p(T)<4.5 GeV/c) a significant fraction of all produced particles are protons and antiprotons. They show a centrality-scaling behavior different from that of pions. The pmacr;/pi and p/pi ratios are enhanced compared to peripheral Au+Au, p+p, and e(+)e(-) collisions. This enhancement is limited to p(T)<5 GeV/c as deduced from the ratio of charged hadrons to pi(0) measured in the range 1.5<p(T)<9 GeV/c.

Journal Article↗
PubMed2003

Absence of suppression in particle production at large transverse momentum in sqrt[s(NN)]=200 GeV d+Au collisions.

Transverse momentum spectra of charged hadrons with p(T)<8 GeV/c and neutral pions with p(T)<10 GeV/c have been measured at midrapidity by the PHENIX experiment at BNL RHIC in d+Au collisions at sqrt[s(NN)]=200 GeV. The measured yields are compared to those in p+p collisions at the same sqrt[s(NN)] scaled up by the number of underlying nucleon-nucleon collisions in d+Au. The yield ratio does not show the suppression observed in central Au+Au collisions at RHIC. Instead, there is a small enhancement in the yield of high momentum particles.

Journal Article↗
PubMed2003

Suppressed pi(0) production at large transverse momentum in central Au+Au collisions at sqrt[s(NN)]=200 GeV.

Transverse momentum spectra of neutral pions in the range 1<p(T)<10 GeV/c have been measured at midrapidity by the PHENIX experiment at BNL RHIC in Au+Au collisions at sqrt[s(NN)]=200 GeV. The pi(0) multiplicity in central reactions is significantly below the yields measured at the same sqrt[s(NN)] in peripheral Au+Au and p+p reactions scaled by the number of nucleon-nucleon collisions. For the most central bin, the suppression factor is approximately 2.5 at p(T)=2 GeV/c and increases to approximately 4-5 at p(T) approximately 4 GeV/c. At larger p(T), the suppression remains constant within errors. The deficit is already apparent in semiperipheral reactions and increases smoothly with centrality.

Journal Article↗
PubMed1996

Tropical bont tick eradication campaign in the French Antilles. Current status.

The Amblyomma variegatum eradication campaign was officially started in April 1994 in Martinique and in Guadeloupe, including its dependencies of Marie Galante, Desirade and St Martin. A budget of $10.5 and $5.9 million for Guadeloupe and Martinique, respectively, was initially (1991) calculated and considered necessary to achieve the program. However, EEC, the most important donor, estimated that 75% only of this proposal was acceptable, on which it agrees to support a maximum of 50%. The balance had to be provided by French government, local political institutions, and animal owners. The current budget actualized in 1995 by veterinary authorities of Martinique and Guadeloupe is $7,200,000 and $9,900,000 respectively. The program will take 5 years: preparation (1 year), acaricide application (3 years), surveillance (1 year). During this first year, a pilot committee was established, and a project leader was designated for each island. Efforts were essentially oriented to organize the program in the field and to obtain funds from French and local counterparts. Funds allowed the recruitment and training of 19 new agents in Guadeloupe and 9 in Martinique, in addition to personnel already involved in the tick control program. Census of animal owners and identification of cattle started or were developed. Tenders were invited to provide vehicles and acaricides. For the latter, choices were made considering the prices and efficacy as well as funds available. Due to a limited budget and cost of pour-on formulations, pour-on acaricides will be used on a maximum of 30% of animals only. In order to investigate animal owners' reticences and the most appropriate media channels to establish a communication and a training program, a survey was conducted in Guadeloupe on a sample of 301 animal owners. The results are presented. In order to strengthen the chances of success of the campaign in the French islands, it is expected that a similar program will take place soon in infested neighboring islands.

Animals↗
PubMed1994

Conjugates or dsDNA linked to human gammaglobulin inhibit anti-dsDNA antibodies in vitro.

Previous studies have shown that both nucleosides and oligonucleotides linked to isologous gammaglobulin suppress anti-nucleic acid antibody production both in vivo and in vitro. The aim of this study was to determine whether one can make a DNA-human gammaglobulin (HGG) conjugate which can inhibit anti-double stranded DNA (dsDNA) antibodies obtained from a heterogeneous population of systemic lupus erythematosus (SLE) sera. To do so, we constructed conjugates of sonicated dsDNA fragments of 100-400 base pairs covalently linked to HGG with varying degrees of substitution of DNA:HGG. An ELISA inhibition assay was used to determine which conjugate best inhibits the binding of anti-dsDNA antibodies. Conjugate 2, prepared with monomeric HGG (150 kD) with a high degree of substitution (3.72 DNA:HGG) inhibited the binding of anti-dsDNA antibodies from 27 of 31 SLE sera. In addition, this conjugate inhibited the spontaneous formation of anti-dsDNA in vitro by cultured lymphoid cells from selected SLE patients. Together, this data suggests that a 'generic' tolerogen may provide an antigen specific therapy for SLE.

Antibodies, Antinuclear↗
PubMed1990

A novel technique to link either proteins or peptides to gammaglobulin to construct tolerogens.

In order to extend the concept of constructing tolerogens (i.e., compounds which induce immunologic tolerance), we developed a novel method to covalently link either protein or peptide to isologous gammaglobulin. We used disuccinimidyl suberate (DSS) for preparing protein conjugates in solution in a novel use of this reagent. We tested the efficacy of this method in two different experimental models: in the first, we found that administration of pigeon cytochrome C conjugated to mouse IgG in vivo induces T cell unresponsiveness in vitro. In the second, we induced unresponsiveness to factor VIII light chain both in newborn and, more importantly, in adult mice already immune to factor VIII. We hope that this simple method will provide a powerful tool to construct tolerogens useful in the specific treatment of either allergic or autoimmune diseases.

Animals↗
PubMed1989

Immunologic tolerance to DNA in B cell lines from both normal and autoimmune mice.

We examine whether B cell lines enriched for DNA specificity from either autoimmune (BWF1) or normal mice (Balb/c) can be rendered unresponsive to autoantigen in terms of the specific suppression of direct antibody-forming cells to DNA. These B cell lines were both Lyt-1 positive and negative. Preincubation with oligonucleotide, covalently linked to mouse gamma-globulin, specifically suppressed the antigen-driven response elicited by DNA horse red blood cells in B cell lines from both strains of mice. There is a 5-fold difference in susceptibility to DNA-specific tolerance induction between B cell lines of BWF1 and Balb/c mice. Thus, B cells from autoimmune mice do not appear to have an inherent absolute defect in being rendered tolerant to autoantigen, but are relatively less susceptible to DNA-specific tolerance than nonautoimmune cell lines.

Animals↗
PubMed1988

Oligonucleotide linked to human gammaglobulin specifically diminishes anti-DNA antibody formation in cultured lymphoid cells from patients with systemic lupus erythematosus.

In vitro studies were undertaken to determine whether the level of anti-DNA antibody can be modulated in humans with systemic lupus erythematosus (SLE). DNA fragments of different sizes, i.e., oligonucleotide (N20-30) or oligonucleotide (N10-100), were covalently linked either to human gammaglobulin (HGG) and used as tolerogens or to keyhole limpet hemocyanin and used as immunogens. Experiments were done to determine whether such tolerogens specifically diminish antibodies to denatured DNA, native DNA, or both. PBL were obtained from 87 patients with SLE, 55 of whom spontaneously produced anti-DNA antibodies in vitro. Furthermore, of these 55 test subjects 23 made anti-DNA antibodies in response to antigen challenge in vitro. Exposure of PBL to tolerogenic oligonucleotide-HGG reduced spontaneous antibody formation in 34 of the 55 patients' PBL and abrogated the in vitro-induced response in all instances. The suppression was tolerogen specific. In some SLE patients lymphoid cells were suppressed by both (N10-100)-HGG and (N20-30)-HGG, while in others lymphoid cells were suppressed by only one. Longitudinal studies of spontaneous antibody production showed that the same tolerogens consistently reduced anti-DNA antibody formation in lymphoid cells of 12 patients on several occasions over a 2-yr interval, but in 8 others the results were either variable or inconsistent. In contrast, tolerogens consistently abrogated the antigen-induced response in all 23 patients' PBL. These results obtained in humans in vitro suggest that the principle of carrier-determined tolerance could be applied as a specific therapy for SLE in vivo.

Antibodies, Antinuclear↗